Danex is young Emerging star in pharmaceutical space which is committed for healthier tomorrow by providing high quality Medicine in Cardiology, Diabetology and Nutraceutical therapy area.Danex is incorporated in 30th March 2024 with a mission to help Patient with High quality and affordable Medicine with trust. Company has been formed with strong mission and long vision to be the Global Pharmaceuticals company to address gap area in treatment of Diabetes and Cardiovascular disease and address the unmet need in Nutritional therapy for Diabetes, obesity and Cvd Risk.

A Team of Highly experienced Professionals with more 40 years of Experience from Large MNC and Indian Company in the pharmaceutical industry who have launched many 1st time in India molecule in the entire Professionals career are now poised to make the difference through Danex Biolife Science.

A dedicated and highly experienced Board member from India and Abroad who joined together to make difference in the area of Diabetology and Cardiology and Nutraceutical therapy. Having Partnering with India’s leading Manufacturers who are approved by National and Internal Body.with WHO GMP Certified Manufacturing Facilities across the country. Aiming to bring new and innovative product in Diabetology and Cardiology therapy.

We are committed to our employee welbeing and work balance by providing better Work culture.